The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
PenTide Therapeutics Limited is a pre-clinical stage biotech company founded in Hong Kong in 2021. We strive to develop next-generation drug delivery technologies and provide novel therapeutics for unmet medical needs.
We are focused on the development of innovative drug delivery systems leveraging on our proprietary technologies in: i) improving treatment effects of existing drugs via 505(b)(2) registration; ii) cell-penetrating peptide-based delivery for antibody, non-viral vaccine, or gene therapy; and iii) brain targeted delivery of peptide drugs to treat Alzheimer’s and Parkinson’s Diseases.
Our differentiated product pipeline will fulfil unmet medical needs and provide improved convenience and compliance.
Our proprietary technologies for drug delivery enhancement enable non-invasive, fast and sustained drug delivery from small molecules to biologics.
1. Intranasal Semaglutide
2. Palonosetron Intranasal Spray